Literature DB >> 8492911

Estradiol induces plasticity of gabaergic synapses in the hypothalamus.

A Párducz1, J Perez, L M Garcia-Segura.   

Abstract

The number of axosomatic synapses on arcuate neurons of the adult rat hypothalamus fluctuates following the sequence of increasing circulatory estradiol during the ovarian cycle. To determine whether estrogen is affecting GABAergic synaptic contacts we studied the number of GABA-immunoreactive axosomatic synapses in adult ovariectomized rats injected either with 17 beta estradiol (100 micrograms/100 g body weight) or with sesame oil vehicle. The number of immunoreactive axosomatic synapses was significantly reduced in estradiol-treated rats (77 +/- 8 vs 56 +/- 6 synapses per 1000 microns of perikaryal membrane in control and estradiol-treated rats, respectively) while the number of non-immunoreactive synapses was not significantly affected by the hormonal treatment (44 +/- 6 vs 35 +/- 5 synapses per 1000 microns of perikaryal membrane in control and estradiol-treated rats, respectively). Estradiol administration also resulted in a significant decrease in the percentage of perikaryal membrane covered by immunoreactive synapses. These results suggest that physiological levels of estradiol may induce a remodeling of GABAergic inhibitory inputs on arcuate neurons.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8492911     DOI: 10.1016/0306-4522(93)90203-r

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

1.  Individual differences in estrogen receptor alpha in select brain nuclei are associated with individual differences in aggression.

Authors:  Brian C Trainor; Kelly M Greiwe; Randy J Nelson
Journal:  Horm Behav       Date:  2006-06-06       Impact factor: 3.587

Review 2.  Gonadal steroids and astroglial plasticity.

Authors:  L M Garcia-Segura; J A Chowen; M Dueñas; A Parducz; F Naftolin
Journal:  Cell Mol Neurobiol       Date:  1996-04       Impact factor: 5.046

Review 3.  Potential neuronal mechanisms of estrogen actions in synaptogenesis and synaptic plasticity.

Authors:  F Naftolin; C Leranth; T L Horvath; L M Garcia-Segura
Journal:  Cell Mol Neurobiol       Date:  1996-04       Impact factor: 5.046

4.  Estrogen biphasically modifies hypothalamic GABAergic function concomitantly with negative and positive control of luteinizing hormone release.

Authors:  E J Wagner; O K Ronnekleiv; M A Bosch; M J Kelly
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

5.  Gonadal steroids differentially modulate the actions of orphanin FQ/nociceptin at a physiologically relevant circuit controlling female sexual receptivity.

Authors:  A Borgquist; V M Rivas; M Kachani; K Sinchak; E J Wagner
Journal:  J Neuroendocrinol       Date:  2014-05       Impact factor: 3.627

Review 6.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

7.  Neuroplastic changes in the hypothalamic arcuate nucleus: the estradiol effect is accompanied by increased exoendocytotic activity of neuronal membranes.

Authors:  A Párducz; T Szilágyi; S Hoyk; F Naftolin; L M Garcia-Segura
Journal:  Cell Mol Neurobiol       Date:  1996-04       Impact factor: 5.046

8.  Chronic but not acute estradiol treatment protects against the neurodegenerative effects of N-methyl-D-aspartate receptor antagonists.

Authors:  William Dribben; Brian Nemmers; Anthony Nardi; George Taylor; John Olney; Nuri Farber
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

9.  Estradiol-induced synaptic remodeling of tyrosine hydroxylase immunopositive neurons in the rat arcuate nucleus.

Authors:  Eszter Csakvari; Anita Kurunczi; Zsofia Hoyk; Andrea Gyenes; Frederick Naftolin; Arpad Parducz
Journal:  Endocrinology       Date:  2008-04-17       Impact factor: 4.736

10.  Changes in glial fibrillary acidic protein (GFAP) immonureactivity reflect neuronal states.

Authors:  Ferenc Hajós
Journal:  Neurochem Res       Date:  2008-05-16       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.